Friday, September 4, 2026
27.2 C
Bengaluru

What’s the Mood of Indian Pharma? A Poll by MedicinMan

We are in the middle of huge crisis and uncertainty. The Covid-19 crisis is taking a toll on Indian Pharma Leaders. Many leaders are not sure – what is of critical importance at this time? What are they are supposed to do and how they are supposed to do it? There are enormous challenges that majority of leaders have not faced before.

  • Many leaders had to take a pay-cut, downsize their teams, and deliver bad news up and down the organization.
  • Working from home for months and feeling stressed because there is no light at the end of the tunnel.
  • What can you do to stay focused and upbeat during this prolonged uncertain time?
  • How can you learn to reframe the situation that you are facing?
  • Who can you vent your frustration and feelings to? And, what can you do to recharge when most of your usual outlets are not available?

Leading effectively — especially during a crisis, needs emotional maturity and patience. If you can’t retain your cool and composure in the face of frustration and adversity, you won’t be able to keep others in your team, calm.

While this is really difficult, how can we change our focus and think about it differently?

This is probably the biggest growth opportunity that you will ever have in your career, if only you can manage through this and make sure your team weather this storm. Let’s discover the power of emotional intelligence in leadership, and challenge how leaders can develop this competency to not only improve self-management but also handle interpersonal relationships judiciously and empathetically.

Get an insight into the Emotional State of Indian Pharma professionals at the Digital Excellence Pharma Academy.

Register now for our webinar, “Leading with Emotional Intelligence” by Deep Bhandari on Wednesday 23rd September on https://www.credoweb.in/discussion/558/leading-with-emotional-intelligence?anchor=1167

Hot this week

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

India has two very different pharmaceutical regulators living inside...

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

How To See Dr Reddy’s Nestle In The Wellness Shift

GLP-1 medicines such as semaglutide and tirzepatide are changing...

Topics

Pharmacy of the World Pricing Paradox

India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

India has two very different pharmaceutical regulators living inside...

MedicinMan Pharma Pulse: August 2026

🚀 The Mega-Merger That Wasn't Early August saw the...

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...

How To See Dr Reddy’s Nestle In The Wellness Shift

GLP-1 medicines such as semaglutide and tirzepatide are changing...

How To Power The India Biopharma Regulatory Revolution Now

Beyond the Pharmacy of the World: Why India's Biopharma...

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

Something remarkable has happened in the Indian pharmaceutical market....

Can India Pivot From Low-Cost Medical Tourism to Trusted Medical Value Travel?

C-Suite Executive Summary India stands at a pivotal juncture in...
spot_img

Related Articles

spot_imgspot_img